| Bongsun Shin, | |
|
2648 W Ball Rd Apt 154, Anaheim, CA 92804-5090 | |
| (213) 292-3137 | |
| Not Available |
| Full Name | Bongsun Shin |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse |
| Location | 2648 W Ball Rd Apt 154, Anaheim, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033744495 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 719108 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Bongsun Shin, 2648 W Ball Rd Apt 154, Anaheim, CA 92804-5090 Ph: () - | Bongsun Shin, 2648 W Ball Rd Apt 154, Anaheim, CA 92804-5090 Ph: (213) 292-3137 |
News Archive
Researchers at the University of Warwick have identified a particular combination of health problems that can double the risk of heart attack and cause a three-fold increase in the risk of mortality.
Should germline genetic testing be offered to all patients with breast cancer? The American College of Medical Genetics and Genomics addresses this important question in a new statement published in Genetics in Medicine, "Points to Consider: Is There Evidence to Support BRCA1/2 and Other Inherited Breast Cancer Genetic Testing for All Breast Cancer Patients? A Statement of the American College of Medical Genetics and Genomics."
A major research effort to develop medical products to diagnose, prevent and treat the short- and long-term consequences of radiation exposure after a radiological or nuclear terrorist attack has been renewed by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
Shire plc, the global specialty biopharmaceutical company, today announced topline results from FAST-3 (For Angioedema Subcutaneous Treatment), the largest of the Phase III trials studying the use of Firazyr (icatibant) for treatment of acute attacks of hereditary angioedema (HAE).
Scientists from the Kimmel Cancer Center at Jefferson have found that interleukin-10 production in tumor cells is a possible prognostic factor in patients with advanced melanoma who are treated with autologous melanoma cell vaccine. They are presenting their data at the 2010 ASCO Annual Meeting in Chicago (Abstract #8588).
› Verified 8 days ago
Haley Martin, Registered Nurse Medicare: Medicare Enrolled Practice Location: 3440 E La Palma Ave, Anaheim, CA 92806 Phone: 317-644-9054 | |
Femila Biju Joseph, NP Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 303 N East St, Anaheim, CA 92805 Phone: 714-491-1771 | |
Smriti Shrestha Thebe, Registered Nurse Medicare: Medicare Enrolled Practice Location: 3440 E La Palma Ave, Anaheim, CA 92806 Phone: 714-644-6650 | |
Elizabeth Pham, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1910 S Union St Unit 1077, Anaheim, CA 92805 Phone: 562-334-7168 | |
Joyce Chen, Registered Nurse Medicare: Medicare Enrolled Practice Location: 421 N Brookhurst St Ste 218, Anaheim, CA 92801 Phone: 949-431-6363 | |
Ms. Terry York, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1900 E La Palma Ave Ste 101, Anaheim, CA 92805 Phone: 714-399-3480 Fax: 714-399-3481 |